Ticker Details
Quidel Corporation Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.
IPO Date:	February 1, 1991
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$808.75M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 2.02%
Avg Daily Range (30 D):	$0.54 | 4.45%
Avg Daily Range (90 D):	$0.68 | 3.72%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	2.47M
Avg Daily Volume (90 D):	1.67M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	80
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	5,818
Avg Institutional Trade:	$3.3M
Avg Institutional Trade (30 D):	$3.03M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.26M
Avg Closing Trade (30 D):	$3.78M
Avg Closing Trade (90 D):	$4.02M
Avg Closing Volume:	83.71K

News

May 8, 2026 @ 8:47 AM Pregnancy Detection Kits Market Analysis Report 20... Source: Researchandmarkets.Com

Mar 9, 2026 @ 1:05 PM Rice Hall James Buys QuidelOrtho Stock Source: John Ballard

Mar 2, 2026 @ 2:18 AM QuidelOrtho Corp Director Purchases 10k Shares as ... Source: Adé Hennis

Sep 4, 2025 @ 9:35 PM QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is ... Source: Bragar Eagel & Squire, P.C.

Aug 28, 2025 @ 3:00 AM Lateral Flow Assays Market to Grow at a CAGR of 7.... Source: Wissen Research

Financials
	TTM	Q4 2026	Q4 2025
Basic EPS	$-17.8	$-1.35	$-1.9
Diluted EPS	$-17.8	$-1.35	$-1.9
Revenue	$2.66B	$619.8M	$723.6M
Gross Profit
Net Income / Loss	$-1210.9M	$-91.8M	$-130.7M
Operating Income / Loss	$-983.6M	$-31.8M	$-66.3M
Cost of Revenue
Net Cash Flow	$13.2M	$-29.4M	$71.7M
PE Ratio